Erythropoetin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

Neuroscience

Volumn 76, Issue 1, 1996, Pages 105-116

  Morishita, E ^a   Masuda, S ^a   Nagao, M ^a   Yasuda, Y ^b   Sasaki, R ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

astrocyte; erythropoietin; erythropoietin receptor; glutamate neurotoxicity; ischemia; neuron

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CALCIUM TRANSPORT; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; ANIMAL; CELL STRAIN; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL;

ANIMALS; CELL DEATH; CEREBRAL CORTEX; ERYTHROPOIETIN; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS;

EID: 0030636320     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00306-5     Document Type: Article

References (55)

1. Abe K., Saito H. Protective effect of epidermal growth factor on glutamate neurotoxicity in cultured cerebellar neurons. Neurosci. Res. 14:1992;117-123.
2. Benveniste H., Drejer J., Schousboe A., Diemer N. H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
3. Chao C. C., Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Devl Neurosci. 16:1994;172-179.
4. Cheng B., Goodman Y., Begley J. G., Mattson M. P. Neurotrophin-4/5 protects hippocampal and cortical neurons against energy deprivation- and excitatory amino acid-induced injury. Brain Res. 650:1994;331-335.
5. Cheng B., Mattson M. P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
6. Cheng B., Christakos S., Mattson M. P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
7. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. Choi D. W., Rothman S. M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. A. Rev. Neurosci. 13:1990;171-182.
9. Choi D. W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
10. Choi D. W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
11. Digicaylioglu M., Bichet S., Marti H. H., Wenger R. H., Rivas L. A., Bauer C., Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. natn. Acad. Sci. U.S.A. 92:1995;3717-3720.
12. Fernandez S. M., Novelli A. Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity. Fedn Eur. biochem. Socs Lett. 335:1993;124-131.
13. Freese A., Finklestein S. P., DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 575:1992;351-355.
14. Goto M., Akai K., Murakami A., Hashimoto C., Tsuda E., Ueda M., Kawanishi G., Takahashi N., Ishimoto A., Chiba H., Sasaki R. Production of recombinant human erythropoietin in mammalian cells: host-cell dependency of the biological activity of the cloned glycoprotein. Bio/Technology. 6:1988;67-71.
15. Guan J., Williams C., Gunning M., Mallard C., Gluckman P. The effect of IGF-I treatment after hypoxic-ischemic brain injury in adult rats. J. cerebr. Blood Flow Metab. 13:1993;609-616.
16. Hatten M. E., Lynch M., Rydel R. E., Sanchez J., Joseph-Silverstein J., Moscatelli D., Rifkin D. B. In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Devl Biol. 125:1988;280-289.
17. Jacobson L. O., Goldwasser E., Fried W., Plzak L. Role of the kidney in erythropoiesis. Nature. 179:1957;633-634.
18. Kinoshita A., Yamada K., Hayakawa T., Kataoka K., Mushiroi T., Kohmura E., Mogami H. Modification of anoxic neuronal injury by human recombinant epidermal growth factor and its possible mechanisms. J. Neurosci. Res. 25:1990;324-330.
19. Konishi Y., Chui D.-H., Hirose H., Kunishita T., Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609:1993;29-35.
20. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
21. Lin C.-S., Lim S.-K., D'Agati V., Constantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Devel. 10:1996;154-164.
22. Lindholm D., Dechant G., Heisenberg C. P., Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5:1993;1455-1464.
23. Liu Z.-Y., Chin K., Noguchi C. T. Tissue specific expression of human erythropoietin receptor in transgenic mice. Devl Biol. 166:1994;159-169.
24. MacMillan V., Judge D., Wiseman A., Settles D., Swain J., Davis J. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage. Stroke. 24:1993;1735-1739.
25. Marti H. H., Wenger R. H., Rivas L. A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:1996;666-676.
26. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F., Tabira T., Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J. biol. Chem. 268:1993;11208-11216.
27. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J. biol. Chem. 269:1994;19488-19493.
28. Matsuda S., Wen T.-H., Morita F., Ohtuka H., Igase K., Yoshimura H., Sakanaka M. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci. Lett. 204:1996;1-4.
29. Mattson M. P., Murrain M., Guthrie P. B., Kater S. B. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9:1989;3728-3740.
30. Mattson M. P., Kumar K. N., Wang H., Cheng B., Michaelis E. K. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci. 13:1993;4575-4588.
31. Morishita E., Narita H., Nishida M., Kawashima N., Yamagishi K., Masuda S., Nagao M., Hatta H., Sasaki R. Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells. Blood. 88:1996;465-491.
32. Nagao M., Masuda S., Abe S., Ueda M., Sasaki R. Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. Biochem. biophys. Res. Commun. 188:1992;888-897.
33. Nakata N., Kato H., Kogure K. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 605:1993;354-356.
34. Prehn J. H., Backhauss C., Krieglstein J. Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. cerebr. Blood Flow Metab. 13:1993;521-525.
35. Prehn J. H., Krieglstein J. Opposing effects of transforming growth factor-beta 1 on glutamate neurotoxicity. Neuroscience. 60:1994;7-10.
36. Pulsinelli W. A., Brierly J. B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
37. Rosenberg P. A., Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103:1989;162-168.
38. Rothman S. M., Thurston J. H., Hauhart R. E. Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience. 22:1987;471-480.
39. Schmechel D. E. and Marangos P. J. (1983) Neuron specific enolase as a marker for differentiation in neurons and neuroendocrine cells. In Current Methods in Cellular Neurobiology (eds Barker J. and Mckelvey J.), Vol. 1, pp. 1-62. John Wiley, New York.
40. Shigeno T., Mima T., Takakura K., Graham D. I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1993;2914-2919.
41. Shimohama S., Ogawa N., Tamura Y., Akaike A., Tsukahara T., Iwata H., Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res. 632:1993;296-302.
42. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S., Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 164:1993;55-58.
43. Siejo B. K. Historical overview: calcium, ischemia and death of brain cells. Ann. N. Y. Acad. Sci. 522:1988;638-661.
44. Skaper S. D., Negro A., Dal T. R., Facci L. Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of monosialogangliosides. J. Neurosci. Res. 33:1992;330-337.
45. Tan C.-C., Eckardt K.-U., Firth J. D., Ratcliffe P. J. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol. 263:1992;F474-F481.
46. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144:1992;49-52.
47. Tsukahara T., Yonekawa Y., Tanaka K., Ohara O., Watanabe S., Kimura T., Nishijima T., Taniguchi T. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery. 34:1994;323-331.
48. Uesugi A. Photomicrography of immunohistochemical tissue-sections: selection and preparation of filter. Jap. J. med. Photography. 24:1990;16-24.
49. Vibulsreth S., Hefti F., Ginsberg M. D., Dietrich W. D., Busto R. Astrocytes protect cultured neurons from degeneration induced by anoxia. Brain Res. 422:1987;303-311.
50. Watkins J. C., Olverman H. J. Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci. 10:1987;265-272.
51. Wen T.-C., Matsuda S., Yoshimura H., Kawabe T., Sakanaka M. Ciliary neurotrophic factor prevents ischemia-induced learning disability and neuronal loss in gerbils. Neurosci. Lett. 191:1995;55-58.
52. Wu H., Liu X., Jaenisch R., Lodish H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:1995;59-67.
53. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.
54. Yasuda Y., Nagao M., Okano M., Masuda S., Sasaki R., Konishi H., Tanimura T. Localization of erythropoietin and erythropoietin-receptor in postimplantation mouse embryo. Devel. Growth Differ. 35:1993;711-722.
55. Youssoufian H., Longmore G., Neumann D., Yoshimura A., Lodish H. F. Structure, function, and activation of the erythropoietin receptor. Blood. 81:1993;2223-2236.